prolaio eVO2peak Module vs Viz HCM
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if your primary need is to longitudinally monitor and estimate peak oxygen consumption for cardiovascular research or detailed patient assessment. This tool is ideal for leveraging real-world data from qualified wearable sensors to provide an adjunctive aid in evaluating cardiovascular fitness and risk over time.
View prolaio eVO2peak Module →Choose Viz HCM if…
Choose Viz HCM if your priority is the rapid, real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from ECGs within a hospital or health system environment. This solution excels at streamlining care coordination by providing immediate alerts to multidisciplinary teams and automating patient direction to specialists, significantly reducing diagnosis time for this specific condition.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | Viz HCM |
|---|---|---|
| Deployment | Cloud | Unknown |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM emphasizes seamless integration with existing hospital IT systems like EHR and PACS, and provides mobile-based alerts for multidisciplinary care teams, suggesting a highly integrated and accessible user experience for clinicians. Prolaio eVO2peak Module focuses on processing remote sensor data, which is convenient for data collection but provides less detail on the clinical user interface or integration into existing hospital workflows.
Clinical Value
Viz HCMViz HCM offers real-time AI-powered detection of Hypertrophic Cardiomyopathy (HCM) from ECGs, with a proven ability to reduce time to diagnosis and treatment for this critical condition, supported by extensive real-world evidence and publications. Prolaio eVO2peak Module provides an adjunctive aid for estimating peak oxygen consumption using wearable data, which is valuable for cardiovascular assessment but less immediately impactful on critical disease pathways.
Pricing & Value
Viz HCMViz HCM offers a subscription-based model with transparent pricing details, including information on CMS reimbursement for specific CPT codes, which significantly enhances its value proposition for healthcare systems. Prolaio eVO2peak Module only states 'contact for pricing,' offering no immediate transparency on cost or potential reimbursement.
Enterprise Readiness
Viz HCMViz HCM explicitly highlights seamless integration with existing hospital IT systems, including EHR and PACS, and is deployed across over 1,700 hospitals and health systems. This demonstrates a robust capability for enterprise-level deployment and workflow integration. While Prolaio eVO2peak Module is cloud-based and HIPAA/FDA compliant, it lacks specific details on deep integration with hospital IT infrastructure.
Innovation
Viz HCMViz HCM's innovation lies in its comprehensive approach, combining real-time AI-powered ECG analysis for HCM detection with intelligent care coordination, mobile alerts, and automated patient direction to specialists, creating a new regulatory category for cardiovascular machine learning-based notification software. Prolaio eVO2peak Module innovates by using deep learning with diverse wearable sensor data to estimate eVO2peak, providing longitudinal insights. However, Viz HCM's integrated workflow orchestration represents a broader innovation in care delivery.
Support & Docs
Viz HCMViz.ai, as an enterprise-focused company, provides a comprehensive support structure including a 24/7 urgent phone line, email support, a knowledge base with troubleshooting guides, and extensive customer resources and user guides. Prolaio's website mentions resources for clinicians and researchers, but specific details on dedicated customer support channels or extensive documentation are less prominent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | Viz HCM |
|---|---|---|
| Tool Name | prolaio eVO2peak Module | Viz HCM |
| Company | Prolaio | Viz.ai |
| Primary Function | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. | Uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care. |
| Key Inputs | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors | Real-time ECG analysis from electrocardiograms |
| Key Outputs/Benefits | Estimates peak oxygen consumption (eVO2peak); Provides information as an adjunctive aid in clinical evaluation; Enables high-density, longitudinal data collection | AI-powered ECG analysis for HCM detection; Mobile-based alerts and notifications; Automated direction of patients to appropriate care specialists; Reduces time to diagnosis and treatment for HCM |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology, Emergency Medicine, Hospital Medicine |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and Viz HCM.